Giving with Passion: The New Philanthropists

Steven Burrill Donations to scientists and scientific projects today often take on a personal flavor. Many relatively young and wealthy entrepreneurs direct their dollars to scientific causes that tap into personal concerns and strongly felt and articulated visions. "I ... [feel] passionately about ... science and technology and the need to build an economy and a society based around science and technology. I believe the education system by and large has not been keeping up in providing our yo

Written byHarvey Black
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share


Steven Burrill
Donations to scientists and scientific projects today often take on a personal flavor. Many relatively young and wealthy entrepreneurs direct their dollars to scientific causes that tap into personal concerns and strongly felt and articulated visions.

"I ... [feel] passionately about ... science and technology and the need to build an economy and a society based around science and technology. I believe the education system by and large has not been keeping up in providing our young people the excitement to be in science and technology or the skills to do that," says Steven Burrill, the 54-year-old CEO of Burrill & Co., a merchant bank in San Francisco. "I don't see a lot of kids wanting to grow up to be Bill Gates. And that bothers me. So my passion for that causes me to give where that passion is." Burrill recently gave "in excess of $50,000" (he ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies